Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 101487
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.101487
Table 3 Performance of fecal immunological test for detecting colorectal lesions
Lesions
Sensitivity (95%CI)
Specificity (95%CI)
PPV (95%CI)
NPV (95%CI)
Accuracy (95%CI)
Nonadvanced adenoma61.3 (59.1-63.6)45.5 (44.7-46.4)14.3 (13.5-15.0)88.9 (88.1-89.6)47.6 (47.6-47.6)
Advanced adenoma56.1 (55.1-57.0)45.5 (44.7-46.4)47.3 (46.5-48.2)54.3 (53.3-55.3)50.5 (50.5-50.5)
Colorectal cancer47.3 (43.1-51.6)44.3 (43.7-45.0)1.8 (1.6-2.0)97.5 (97.2-97.8)44.4 (44.4-44.4)
    Stage 0-I58.4 (50.7-66.2)44.3 (43.7-45.0)0.7 (0.5-0.8)99.4 (99.3-99.6)44.4 (44.4-44.4)
    Stage II-IV42.7 (37.7-47.7)44.3 (43.7-45.0)1.2 (1.0-1.3)98.1 (97.8-98.3)44.3 (44.3-44.3)
Advanced neoplasm58.2 (56.1-60.2)44.8 (44.1-45.4)9.7 (9.2-10.2)91.3 (90.8-91.8)46.0 (46.0-46.0)
Any neoplasm56.5 (55.6-57.3)45.5 (44.7-46.4)52.5 (51.6-53.3)49.6 (48.6-50.5)51.2 (51.2-51.2)